What is the most recent earnings date for AFX stock?
CARL ZEISS MEDITEC AG - BR (AFX.DE) last reported earnings on 2/12/2026.
CARL ZEISS MEDITEC AG - BR (AFX.DE) Earnings History & Surprises
FRA:AFX • DE0005313704
Current stock price
24.32 EUR
-0.68 (-2.72%)
Last:
AFX.DE Earnings overview
Past quarterly earnings results for CARL ZEISS MEDITEC AG - BR (AFX.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q2 / 2026
- EPS Estimate
- €0.41
- Revenue Estimate
- 533.17M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q1 / 2026
- EPS Reported
- €0.03
- EPS Surprise
- -88.15%
- Revenue Surprise
- -4.50%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 0.03 | 0.25 | -88.15% | -83.33% | 467M | 489.02M | -4.50% | -4.79% |
| Q4 2025 | 0.59 | 0.65 | -9.05% | -14.49% | 627.545M | 609.76M | 2.92% | 8.27% |
| Q3 2025 | 0.32 | 0.48 | -33.88% | -15.79% | 549.631M | 555.99M | -1.14% | 1.92% |
| Q2 2025 | 0.52 | 0.46 | 13.25% | - | 560.016M | 539.7M | 3.76% | 18.62% |
| Q1 2025 | 0.18 | 0.28 | -36.67% | -57.14% | 490.5M | 486.5M | 0.82% | 3.26% |
| Q4 2024 | 0.69 | 0.50 | 37.18% | -28.13% | 579.627M | 593.86M | -2.40% | -0.01% |
| Q3 2024 | 0.38 | 0.59 | -35.88% | -63.11% | 539.3M | 538.65M | 0.12% | 0.78% |
| Q2 2024 | 0.52 | 0.48 | 8.55% | -24.64% | 472.125M | 509.59M | -7.35% | -6.36% |
| Q1 2024 | 0.42 | 0.33 | 27.56% | - | 475M | 471.63M | 0.71% | 1.01% |
| Q4 2023 | 0.96 | 0.73 | 30.80% | -16.52% | 579.661M | 587.12M | -1.27% | 1.71% |
| Q3 2023 | 1.03 | 0.82 | 26.32% | 47.14% | 535.121M | 533.98M | 0.21% | 12.07% |
| Q2 2023 | 0.69 | 0.74 | -7.37% | -32.35% | 504.218M | 511.62M | -1.45% | 13.25% |
| Q1 2023 | - | - | 470.261M | - | 14.65% | |||
| Q4 2022 | 1.15 | 0.89 | 29.31% | 91.67% | 569.936M | 511.05M | 11.52% | 27.05% |
| Q3 2022 | 0.70 | 0.76 | -7.90% | -23.91% | 477.495M | 485.85M | -1.72% | 10.83% |
| Q2 2022 | 1.02 | 0.70 | 45.45% | 67.21% | 445.229M | 440.37M | 1.10% | 11.74% |
| Q1 2022 | 0.42 | 0.55 | -23.70% | -19.23% | 410.176M | 389.3M | 5.36% | 11.19% |
| Q4 2021 | 0.60 | 0.69 | -13.28% | - | 448.585M | 491.77M | -8.78% | -27.71% |
| Q3 2021 | 0.92 | 0.64 | 44.24% | 1,433.33% | 430.834M | 394.74M | 9.14% | 70.31% |
| Q2 2021 | 0.61 | 0.55 | 10.08% | 117.86% | 398.456M | 394.77M | 0.93% | -44.27% |
| Q1 2021 | 0.52 | 0.37 | 39.15% | 20.93% | 368.9M | 331.75M | 11.20% | -0.22% |
| Q4 2020 | 0.60 | 0.33 | 83.64% | - | 620.526M | 334.89M | 85.29% | - |
| Q3 2020 | 0.06 | - | - | 252.974M | - | - | ||
| Q2 2020 | 0.28 | - | - | 714.926M | - | - | ||
| Q1 2020 | 0.43 | - | - | 369.7M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-16.59%
Max EPS beat (4)
13.25%
Min EPS beat (4)
-36.67%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
1.59%
Max Revenue beat (4)
3.76%
Min Revenue beat (4)
-1.14%
Analysis
In the last 4 quarters, AFX.DE has beaten EPS estimates in 1 out of 4 releases
AFX.DE has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AFX.DE reported -16.6% below the EPS estimates on average.
In the last 4 quarters, AFX.DE has beaten the revenue estimates by 1.6% on average.
Related analysis
CARL ZEISS MEDITEC AG - BR / AFX.DE Earnings FAQ
Did CARL ZEISS MEDITEC AG - BR (AFX.DE) beat earnings estimates last quarter?
CARL ZEISS MEDITEC AG - BR (AFX.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often CARL ZEISS MEDITEC AG - BR beats earnings estimates?
In the last 4 quarters, CARL ZEISS MEDITEC AG - BR (AFX.DE) has beaten EPS estimates in 1 out of 4 releases.